Literature DB >> 27619242

Mechanical strength vs. degradation of a biologically-derived surgical mesh over time in a rodent full thickness abdominal wall defect.

A Costa1, J D Naranjo1, N J Turner1, I T Swinehart2, B D Kolich3, S A Shaffiey4, R Londono5, T J Keane3, J E Reing2, S A Johnson2, S F Badylak6.   

Abstract

The use of synthetic surgical mesh materials has been shown to decrease the incidence of hernia recurrence, but can be associated with undesirable effects such as infection, chronic discomfort, and adhesion to viscera. Surgical meshes composed of extracellular matrix (i.e., biologically-derived mesh) are an alternative to synthetic meshes and can reduce some of these undesirable effects but are less frequently used due to greater cost and perceived inadequate strength as the mesh material degrades and is replaced by host tissue. The present study assessed the temporal association between mechanical properties and degradation of biologic mesh composed of urinary bladder matrix (UBM) in a rodent model of full thickness abdominal wall defect. Mesh degradation was evaluated for non-chemically crosslinked scaffolds with the use of (14)C-radiolabeled UBM. UBM biologic mesh was 50% degraded by 26 days and was completely degraded by 90 days. The mechanical properties of the UBM biologic mesh showed a rapid initial decrease in strength and modulus that was not proportionately associated with its degradation as measured by (14)C. The loss of strength and modulus was followed by a gradual increase in these values that was associated with the deposition of new, host derived connective tissue. The strength and modulus values were comparable to or greater than those of the native abdominal wall at all time points.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  (14)C Isotope; Biologic mesh; Bioscaffold remodeling; ECM degradation; Mechanical properties; UBM

Mesh:

Substances:

Year:  2016        PMID: 27619242     DOI: 10.1016/j.biomaterials.2016.08.053

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

1.  Dose optimization of decellularized skeletal muscle extracellular matrix hydrogels for improving perfusion and subsequent validation in an aged hindlimb ischemia model.

Authors:  Melissa J Hernandez; Emma I Zelus; Martin T Spang; Rebecca L Braden; Karen L Christman
Journal:  Biomater Sci       Date:  2020-05-20       Impact factor: 6.843

2.  Inductive Remodeling of Extracellular Matrix Scaffolds in the Temporomandibular Joint of Pigs.

Authors:  Bryan N Brown; William L Chung; Jesse Lowe; Samuel T LoPresti; Jonathan Cheetham; Alejandro J Almarza; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2022-05-02       Impact factor: 4.080

Review 3.  Mast Cell-Biomaterial Interactions and Tissue Repair.

Authors:  Emily W Ozpinar; Ariana L Frey; Glenn Cruse; Donald O Freytes
Journal:  Tissue Eng Part B Rev       Date:  2021-01-21       Impact factor: 6.389

Review 4.  Extracellular Matrix Bioscaffolds for Building Gastrointestinal Tissue.

Authors:  George S Hussey; Madeline C Cramer; Stephen F Badylak
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-09-14

5.  Large Hiatal Hernia Repair with Urinary Bladder Matrix Graft Reinforcement and Concomitant Sleeve Gastrectomy.

Authors:  Kent C Sasse; Jonathan Gevorkian; Rachel Lambin; Rami Afshar; Amy Gardner; Aradhana Mehta; John-Henry Lambin; Austin Shinagawa
Journal:  JSLS       Date:  2019 Jan-Mar       Impact factor: 2.172

6.  Biochemical and biomechanical comparisions of decellularized scaffolds derived from porcine subcutaneous and visceral adipose tissue.

Authors:  Maohui Lin; Jinbo Ge; Xuecen Wang; Ziqing Dong; Malcolm Xing; Feng Lu; Yunfan He
Journal:  J Tissue Eng       Date:  2019-11-14       Impact factor: 7.813

7.  Extracellular Matrix Patches for Endarterectomy Repair.

Authors:  Keith B Allen; Joshua D Adams; Stephen F Badylak; H Edward Garrett; Nicolas J Mouawad; Steven W Oweida; Manesh Parikshak; Parvez K Sultan
Journal:  Front Cardiovasc Med       Date:  2021-02-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.